期刊文献+

肝癌组织CD24基因表达及其临床意义 被引量:2

Expression of CD24 in hepatocellular carcinoma tissues and its clinical significance
原文传递
导出
摘要 目的:探讨CD24基因在原发性肝细胞癌(HCC)组织中表达的特征及其临床病理意义。方法:应用RT-PCR及免疫组化方法检测CD24基因在42例肝癌组织、相应42例癌旁组织中的表达,分析其与临床病理特征的相关性。结果:RT-PCR显示,CD24mRNA阳性表达与肝细胞癌组织分化程度(P=0.019)及有否肝内转移有关(P=0.031),与肝细胞癌患者性别、HBsAg状态、术前AFP水平、肿瘤是否有包膜、肿瘤大小、癌肿数目无关(P>0.05);Elivision法显示,CD24蛋白阳性表达与肿瘤的组织分化程度(P=0.025)、有无肝内转移密切相关(P=0.008),而与患者性别、HBsAg状态、术前AFP水平、肿瘤是否有包膜、肿瘤大小、癌肿数目无关(P>0.05)。HCC组织中CD24表达较癌旁组织明显升高。结论:HCC组织中CD24基因表达能促进HCC的发生、发展和转移,可作为判断HCC恶性程度、评价预后的指标。 OBJECTIVE:To explore the express features and clinical significance of CD24 in HCC tissues.METHODS:The expression of CD24 was detected by RT-PCR and immunohistochemistry in 42 cases of hepatocellular carcinoma and 42 cases of paraneoplastic cirrhosis tissue,and the dependability between CD24 and the characteristics of clinic pathology was analyzed.RESULTS:RT-PCR showed that the expression of CD24 mRNA was significantly correlated with the histological differentiation(P=0.019)and intrahepatic metastasis(P=0.031),but not with the sex,level of serum HBsAg,level of preoperative serum α-fetoprotein(AFP),tumor capsula,tumor size,and number of tumor(P0.05).The method of Elivision showed that the expression of CD24 was significantly correlated with the histological differentiation(P=0.025)and intrahepatic metastasis(P=0.008),but not with the sex,level of serum HBsAg,level of preoperative serum α-fetoprotein(AFP),tumor capsula,tumor size,and number of tumor(P0.05).The expression of CD24 in HCC was obviously higher than that in paraneoplastic cirrhosis.CONCLUSION:The expression of CD24 in HCC can promote the oncogenesis,progression and metastasis of HCC,and CD24 may be an index of malignancy and prognosis in HCC tissues.
出处 《中华肿瘤防治杂志》 CAS 2009年第20期1583-1586,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 泉州市科技计划项目(2007Z27)
关键词 肝肿瘤 CD24基因 RT-PCR 免疫组织化学 liver neoplasms CD24 RT-PCR immunohistochemistry
  • 相关文献

参考文献17

  • 1Figarella B D, Moreau H, Pellissier J F, et al. CD24, a signaltransducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle[J]. Acta Neuropathol, 1993, 86(3) :275-284.
  • 2Shirasawa T, Akashi T, Sakamoto K, et al. Gene expression of CD24 core peptide molecule in developing brain and developing non-neuraltissues[J]. Dev Dyn, 1993,198(1):1-13.
  • 3Poncet C, Frances V, Gristina R,et al. CD24, a glycosylphos phatidylinositol-anchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors[J]. Acta Neuropathol, 1996, 91(4) :400-408.
  • 4Jackson D, Waibel R, Weber E, et al. CD24, a signal-transducing molecule expressed on human B cells, is a maior surface antigen on small cell lung carcinomas[J]. Cancer Res, 1992, 52 (19) :5264-5270.
  • 5Senner V, Sturm A, Baur I, et al. CD24 promotes invasion of glioma cells in vivo[J]. J Neuropathol Exp Neurol, 1999,58 (8):795-802.
  • 6Kristiansen G, Denkert C, Schluns K, et al. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival[J]. Am J Pathol, 2002, 161(4):1215-1221.
  • 7Kristiansen G, Winzer K J, Mayordomo E, et al. CD24 expres sion is a new prognostic marker in breast cancer[J]. Clin Cancer Res, 2003, 9(13) :4906-4913.
  • 8KristiansenG, Pilarsky C, Pervan J, et al. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer[J]. Prostate, 2004, 58 (2):183-192.
  • 9Kristiansen G, Sammar M, Altevogt P. Tumour biological aspects of CD24, a mucin like adhesion molecule[J]. J Mol His tol, 2004, 35(3):255-262.
  • 10Kwon G Y, Ha H, Ahn G, et al. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell car cinoma in patients treated with radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2007, 69(4) :1150-1156.

同被引文献17

  • 1Hong-Ji Wei,Tao Yin,Zhu Zhu,Peng-Fei Shi,Yuan Tian and Chun-You Wang Department of Pancreatic Surgery and Laboratory of General Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China.Expression of CD44,CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment[J].Hepatobiliary & Pancreatic Diseases International,2011,10(4):428-434. 被引量:5
  • 2Huang XP, Rong TH, Lin P, et al. Cyclin D1 overexpression in esophageal cancer from southern China and its clinical significance[J]. Cancer Lett, 2006,231(1): 94-101.
  • 3Nair KS, Naidoo R, Chetty R. Expression of the adhesion molecules in esophageal carcinoma and its prognostic value[J]. J Clin Pathol, 2005, 58(4):343-351.
  • 4Natsugoe S, Matsumoto M, Okumura H, et ah Initial metastatic, including micrometastatic, sites of lymph nodes in esophageal squamous cell carcinoma [J]. J Surg Oncol, 2005, 89(1):6-11.
  • 5Komori T, Doki Y, Kabuto T, et al. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers [J]. J Surg Oncol, 2003, 82(1): 19-27.
  • 6Dang C, Zhang Y, Ma Q, et al. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer[J]. J Gastroenterol Hepatol, 2006, 21(5):850-858.
  • 7Sano A, Kato H, Sakurai S, et al. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma[J]. Ann Surg Oncol, 2009, 16(2):506-514.
  • 8Feng HL, Liu YQ, Yang LJ, et al. Expression of CD133 correlates with differentiation of human colon cancer cells [J]. Cancer Biol Ther, 2010, 9(3):216-223.
  • 9Curley MD, Therrien VA, Cummings CL, et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer [J]. Stem Cell, 2009, 27(12) 2875-2883.
  • 10Yasuda H, Tanaka K, Saigusa S, et al. Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer[J]. Oncol Rep, 2009, 22(4):709-717.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部